Latest Nebulizer Stories
Rehabmart.com, an online e-commerce company that sells rehabilitation and medical supplies, has partnered with Evo Medical Solutions, a respiratory product manufacturer, to provide consumers with
MONMOUTH JUNCTION, N.J., June 10, 2011 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced positive data through six treatment cycles (72 weeks total duration) of its Phase 2 clinical trial program for ARIKACEÂ® (liposomal amikacin for inhalation) in cystic fibrosis (CF) patients with Pseudomonas lung infections.
Nebulizer NE-U22V device proven to be one of the most effective ways among all nebulizers to keep asthma symptoms under control while exercising to lose weight. (PRWEB) June 07, 2011 Losing weight is one of the biggest steps that one will take in their entire life.
DENVER, April 8, 2011 /PRNewswire/ -- A state-of-the-art, eFlow Technology nebulizer (PARI Pharma GmbH) has lifted one Denver Zoo orangutan's health and spirits.
CHICAGO, March 21, 2011 /PRNewswire/ -- ICAP Ocean Tomo will auction a patent portfolio disclosing an improved portable medicinal nebulizer on March 31st at the ICAP Ocean Tomo Spring 2011 Live IP Auction in New York.
RICHMOND, Va., March 21, 2011 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSMD), a biopharmaceutical company, announced today that the Company's Investigational New Drug Application (IND) to conduct a pivotal Phase 3 clinical trial of ARIKACE(TM) (liposomal amikacin for inhalation) in nontuberculous mycobacteria (NTM) lung infections has been cleared by the U.S.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.